Results 171 to 180 of about 21,005 (271)

SF3B1 -mutant mis-splicing of UBA1 confers a targetable therapeutic vulnerability through UBA1 inhibition [PDF]

Jonas Thier, Sophia Hofmann, Katharina Miria Kirchhof, Gabriele Todisco, Teresa Mortera‐Blanco, Indira Barbosa, Ann-Charlotte Björklund, André G. Deslauriers, Elli Papaemmanuil, Eirini P. Papapetrou, Eva Hellström‐Lindberg, Pedro Luís Moura, Vanessa Lundin   +12 more
openalex   +1 more source

Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations [PDF]

, 2021
Elise R. Venable, Dong Chen, Constance P. Chen, Kurt Bessonen, Phuong L. Nguyen, Jennifer L. Oliveira, Kaaren K. Reichard, James D. Hoyer, Simon D. Althoff, Dana J. Roh, Mechelle A. Miller, Kebede H. Begna, Mrinal M. Patnaik, Mark R. Litzow, Aref Al‐Kali, David S. Viswanatha, Rong He   +16 more
openalex   +1 more source

SF3B1 mutation as a predictive biomarker for luspatercept efficacy in myeloproliferative neoplasms and MDS/MPN: a clinical study. [PDF]

Ann Hematol
Cui T, Gong J, Zhang X, Zhang J, Wei N, Zheng W, Duan M.   +6 more
europepmc   +1 more source

SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes. [PDF]

PLoS One
Dastpak M, Mimoso CA, Farshchian M, Paraggio CL, Leonard CE, Yin S, Chi B, Nassar KW, Rowe RG, Zhang J, Hou Z, Daley GQ, Adelman K, Reed R.   +13 more
europepmc   +1 more source

Supplementary Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization

, 2023
Zhaoqi Liu, Akihide Yoshimi, Jiguang Wang, Hana Cho, Stanley Chun-Wei Lee, Michelle Ki, Lillian Bitner, Timothy Chu, Harshal Shah, Bo Liu, Anthony R. Mato, Peter P. Ruvolo, Giulia Fabbri, Laura Pasqualucci, Omar Abdel‐Wahab, Raúl Rabadán   +15 more
openalex   +1 more source

Correction: Dhillon et al. Molecular Insights and Therapeutic Advances in Low-Risk Myelodysplastic Neoplasms: A Clinical Review. <i>Cancers</i> 2025, <i>17</i>, 3610. [PDF]

Cancers (Basel)
Dhillon V, Maciejewski J, Balasubramanian SK.   +2 more
europepmc   +1 more source

Main supplemental file from Erythroid Differentiation Enhances RNA Mis-Splicing in <i>SF3B1</i>-Mutant Myelodysplastic Syndromes with Ring Sideroblasts

Pedro Luís Moura, Teresa Mortera‐Blanco, Isabel Juliana Hofman, Gabriele Todisco, Warren W. Kretzschmar, Ann-Charlotte Björklund, Maria Creignou, Michael Hagemann-Jensen, Christoph Ziegenhain, David Cabrerizo Granados, Indira Barbosa, Gunilla Walldin, Monika Jansson, Neil Ashley, Adam J. Mead, Vanessa Lundin, Marios Dimitriou, Tetsuichi Yoshizato, Petter Woll, Seishi Ogawa, Rickard Sandberg, Sten Eirik W. Jacobsen, Eva Hellström‐Lindberg   +22 more
openalex   +1 more source

5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively

, 2019
Daniel Gackowski, Maciej Gawroński, Cassandra M Kerr, Tomas Radivoyevitch, Ewelina Zarakowska, Marta Starczak, Abdulkadir Abakir, Alexey Ruzov, Jaroslaw P. Maciejewski, Ryszard Oliński   +9 more
openalex   +2 more sources

m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis.

Molecules and Cells, 2023
M. Cieśla, P. Ngoc, Sowndarya Muthukumar, G. Todisco, M. Madej, H. Fritz, M. Dimitriou, Danny Incarnato, E. Hellström-Lindberg, C. Bellodi   +9 more
semanticscholar   +1 more source

P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS

HemaSphere, 2022
J. Senapati, S. Verstovsek, L. Masarova, N. Pemmaraju, G. Montalban Bravo, S. Pierce, L. Zhou, G. Garcia-Manero, H. Kantarjian, P. Bose   +9 more
openaire   +2 more sources